Diabetes Flashcards
Glyburide
Glipizide
Glimeperide
Sulfonylureas
Which Sulfonylurea does NOT require a dose adjustment, and you should choose it in renal impairment
Glipizide
MOA sulfonylureas
enhance insulin secretion from pancreatic beta cells (even if glucose is not present)
what are the adverse effects of suflonylureas?
hypoglycemia and weight gain
Repaglinide
Nateglinide
Non-sulfonylurea secretagogues
How does the MOA of nonsulfonylureas differ from its similar group sulfonylureas
shorter onset and duration of action
what is the rare but dangerous adverse effect with metformin?
Lactic acidosis
What are some common AE’s of metformin?
GI (diarrhea, nausea) and interference of B12 absorption
CONTRAINDICATIONS of metformin?
Abnormal CrCl
SCr > 1.4 or 1.5 if male
Liver disease
Metformin
Biguanides
Pioglitazone
Rosiglitazone
Thiazolinediones
Acarbose
Miglitol
Alpha-glucosidase inhibitors
this class of drugs stimulates PPAR-gamma receptors, increasing insulin sensitivity and decreasing plasma fatty acids
Thiazolidinediones
How long do you need to take Pioglitazone and Rosiglitazone for maximum effect?
12 weeks
Of the 2 thiazolidinediones, which increases triglycerides and which decreases them?
INCREASE - rosiglitazone
DECREASE - pioglitazone
what are the main adverse effects of thiazolidinediones?`
fluid retention
hepatotoxicity
increased limb fracture
what should you counsel premenopausal anovulatory women on when starting them on thiazolidinediones?
they may begin to ovulate
MOA alpha-glucosidase inhibitors?
competes with enzymes of small intestine that normally break down complex carbs, delaying the absorption of carbs
What is the main adverse effect of acarbose and miglitol that limits their use?
GI disturbances - flatulence, abdominal discomfort, diarrhea
Alpha-glucosidase inhibitor CONTRAINDICATION?
chronic intestinal disease (IBD)
-avoid if SCr <2 mg/dL
Sitagliptin
Saxagliptin
Linagliptin
Alogliptin
DPP-4 inhibitors
What are the AE’s of the DPP-4 inhibitors?
headache, nasopharyngitis
RARE: hypoglycemia, acute pancreatitis
Canagliflozin
Dapagliflozin
Empagliflozin
SGLT-2 inhibitors
This medication inhibits the receptor responsible for 90% of glucose reabsorption in proximal tubule. Inhibiting this means glucose is excreted in urine
MOA of SGLT-2 inhibitors